Drug recall · October 27, 2021
Omeprazole Delayed-Release Capsules recall
Why: CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Omeprazole Delayed-Release Capsules, 20 mg* (equivalent to 20.6 mg omeprazole magnesium), 24 Hour, 14-count capsules per bottle within a carton, Distributed by Cardinal Health, Dublin, OH 43017, NDC 70000-0232-1
- Lots / codes
BT001594C
- Quantity
- 8,976 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- October 5, 2021 · Voluntary: Firm initiated
- Classified
- October 22, 2021
- Reported
- October 27, 2021
- Ended
- December 6, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Omeprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.